Back to
Beacon Pointe Advisors, LLC
ORIC
Showing 0 of 2 quarters
Position history for
Beacon Pointe Advisors, LLC's holdings in Oric Pharmaceuticals, Inc.
No. Beacon Pointe Advisors exited its ORIC (Oric Pharmaceuticals) position in Q3 2022. Its Q2 2022 13F listed 10,040 shares worth $44,000. Beacon Pointe Advisors first reported ORIC in Q2 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.